Figure 1From: Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetesMPO and CRP levels for the Control, PL, and MMPI groups. MPO and CRP levels for the Control group at D1, and the PL and MMPI groups at D1 and D84. †P < 0.05 versus Control group. # < 0.05 versus D1 of the MMPI group.Back to article page